81 FR 61196 - USPTO Cancer Moonshot Challenge
DEPARTMENT OF COMMERCE
Patent and Trademark Office Federal Register Volume 81, Issue 172 (September 6, 2016)
Patent and Trademark Office
Federal Register Volume 81, Issue 172 (September 6, 2016)
| Page Range | 61196-61198 | |
| FR Document | 2016-21349 |
[Federal Register Volume 81, Number 172 (Tuesday, September 6, 2016)] [Notices] [Pages 61196-61198] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-21349] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE Patent and Trademark Office [Docket No. PTO-C-2016-0032] USPTO Cancer Moonshot Challenge AGENCY: United States Patent and Trademark Office, Commerce. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The United States Patent and Trademark Office (USPTO) publishes this notice to announce the Cancer Moonshot Challenge, which was launched on August 22, 2016, to enlist the public's help to leverage the USPTO's intellectual property data, often an early indicator of meaningful research and development, and combine it with other economic and funding data. This challenge supports the goals and objectives of the National Cancer Moonshot, a Presidential initiative to speed up cancer advances, make more therapies available to more patients, and improve the ability to prevent cancer and detect it at an early stage. This notice provides the public with information on participation and application requirements for the challenge, including the judging criteria, submission requirements, and rules of eligibility. DATES: Challenge Deadline: The deadline for submissions is September 12, 2016, 5:00 p.m. Eastern Standard Time (EST). ADDRESSES: All individuals or entities who wish to participate in the challenge must register and submit their entry through www.challenge.gov. FOR FURTHER INFORMATION CONTACT: For further information, please contact Thomas A. Beach, Office of the Under Secretary and Director, at 571-272-8600. SUPPLEMENTARY INFORMATION: I. About the Challenge Background Cancer is undoubtedly a disease that touches all our lives. Ending cancer as we know it requires the formation of new alliances. As President Obama noted, getting this done isn't just going to take the best and brightest across the medical, research, and data communities-- but millions of Americans owning a stake of it. By harnessing the power of patent data and accelerating the process for protecting the intellectual property that leads to cancer immunotherapy breakthroughs, the USPTO is standing up and doing its part to help bring potentially life-saving treatments to patients, faster. The Challenge With data released through the USPTO Developer Hub, users are building rich visualizations of intellectual property data, an early indicator of meaningful innovation and research and development (R&D), and combining this data with other state or agency data, such as census and bureau of labor statistics, and/or economic and financial data. These types of visualizations demonstrate the power of telling complex stories that lead to impactful insights and ask why the data matters. Similarly, we challenge you to create and illuminate new trend lines and interactive mappings of innovation with visualizations for all types of cancer treatments and diagnostics by combining our data with other unique data. Be sure to list the sources of your data sets (i.e., orange book data from the FDA), tools, and assumptions used to form your conclusion and visualizations. Imagine your data visualizations will be the foundation to empower the Federal Government--as well as the medical, research, and data communities--to make more precise funding and policy decisions based on the commercialization lifecycle of the most promising treatments, while maximizing U.S. competitiveness in cancer investments. Using analytic tools, processes, and other interoperable data sets, we are challenging you to develop interactive visualizations and stories that can help [[Page 61197]] reveal new insights to guide public policy and research to achieve the goal of doubling the rate of progress toward a cure. For example, you could address questions such as: Trending:What new insights can be revealed by correlating R&D spending/funding to breakthrough technologies? How would you define or cluster the broad spectrum of cancer treatments, therapies, and/or diagnostics? What would trace studies of commercially successful treatments from patent to product tell us? What data insights can be gleaned from understanding the time it takes bring patents to patients? What are the peaks and valleys in the landscape of cancer treatment technologies? Policy: If you were the Director of NIH or another agency, given what you have learned from this patent data and your research, how would you prioritize your cancer research budget? (The National Cancer Institute's FY2014 budget was $4.932 billion.) Based on cluster mapping of cancer treatments, therapies, and/or diagnostics, what policy would you put in place to promote certain technologies? For example, would you promote treatment to make cancer a livable disease verses curing it? Is there any measurable relationship between patent data, clinical trial data, and time to it takes for the technology to be in the hands of the patient? If so, how (and with what catalyst for innovation and policy changes) would you advise the VPOTUS for the Cancer Moonshot? Resources The USTPO has released a curated data set consisting of 269,353 patent documents (published patent applications and granted patents) spanning the 1976 to 2016 period. This data and associated documentation explaining our methodology can be found on the USPTO Developer Hub. Prizes First Place: $5,000.00 Second Place: $3,000.00 Third Place: $2,000.00 More Information About the Cancer Moonshot Initiative As the President's Cancer Moonshot Initiative looks to build public-private partnerships with industry, governments, health systems, non-profits, philanthropy, research institutes, patients, and academia, those interested in advancing the Cancer Moonshot can join today by visiting www.whitehouse.gov/CancerMoonshot. II. Judging Criteria Creativity & Innovation (20%) [cir] Uniqueness and innovation in approach to revealing new insights to guide public policy and research. [cir] Concept should be original, fill a gap, or answer a question in a manner that is not already available. Evidence Base & Effectiveness (20%) [cir] Provide meaningful insight, including potential actions and discoveries, using patent-related data to better inform funding and policy decisions or uncover insights into the cancer R&D process. [cir] How did you arrive at and validate your story? Did you include additional complimentary datasets to help solidify your story? What additional knowledge sources did you use? Value to Public (20%) [cir] Concept should add value to the medical, research, or data communities and policymakers, allowing them to make more informed funding and policy decisions based on the patterns and trends of innovation in cancer diagnosis and treatment. Usability (20%) [cir] The design elements should attract, engage, and influence actions from the public and policymakers. Functional Product (20%) [cir] The visualization should have demonstrable functionality as described in project description. III. How To Enter By September 12, 2016, 5:00 p.m. Eastern Standard Time, submit the following items through www.challenge.gov: A story (maximum 1,000 words). Written in English, tell the story of your visualization and walk users through how to use your visualization. The document must describe how your visualization provides meaningful insight, including potential actions and/or discoveries. Access to and testing instructions for your submission. This can be appended to your visualization description and does not count toward the 1,000 word maximum. Link to the submission. We will not accept any submission without a link. IV. Rules To be eligible to win a prize under this challenge, an individual or entity: (1) Shall have registered to participate in the competition under the rules promulgated by the USPTO. (2) Shall have complied with all the requirements under this section. (3) In the case of a private entity, shall be incorporated in and maintain a primary place of business in the United States; in the case of an individual, whether participating singly or in a group, shall be a citizen or permanent resident of the United States. (4) Shall not be a federal entity or federal employee acting within the scope of their employment. (5) Shall not be a USPTO employee working on their applications or submissions during assigned duty hours. (6) In the case of a federal grantee, shall not use federal funds to develop applications unless consistent with the purpose of their grant award. (7) In the case of a federal contractor, shall not use federal funds from a contract to develop applications or to fund efforts in support of a challenge submission. An individual or entity shall not be deemed ineligible because the individual or entity used federal facilities or consulted with federal employees during a competition if the facilities and employees are made equitably available to all individuals and entities participating in the competition. Entrants must agree to assume any and all risks and waive claims against the Federal Government and its related entities, except in the case of willful misconduct, for any injury, death, damage, or loss of property, revenue, or profits, whether direct, indirect, or consequential, arising from their participation in this prize contest, whether the injury, death, damage, or loss arises through negligence or otherwise. Entrants must also agree to indemnify the Federal Government against third-party claims for damages arising from or related to competition activities. By entering into this competition, entrants represent that the they possess liability insurance or are otherwise financially responsible for: (1) Claims by a third party for death, bodily injury, or property damage, or loss resulting from an activity carried out in connection with participation in the competition, with the Federal Government named as an additional insured under the Entrant's insurance policy, if any; and (2) claims by the Federal Government for damage or loss to government property resulting from such an activity. [[Page 61198]] By submitting an entry to this competition you represent and warrant that your submission: Is your own work and not copied (if we have reason to believe that your submission is not your own work then we may not consider it); does not contain any third party intellectual property rights and/or content that you do not have permission to use; and is not obscene, defamatory, or in breach of any applicable legislation or regulations. The USPTO reserves the right to cancel, suspend, and/or modify the challenge, or any part of it, for any reason, at the USPTO's sole discretion. Submission Requirements Your submission must use at least the cancer research dataset provided by the USPTO. Your submission must be relevant to a U.S. audience and must be in the English language only. You are responsible for the cost and expense (if any) of sending your submission to us and, if your submission is selected, either attending an awards event demo at the USPTO on September 26, 2016, in person or submitting a video of your presentation to be shared at the event. Only one project submission is permitted per person or group. In the event of a dispute over the identity of an entrant, the submission will be deemed submitted by the authorized account holder of the email address submitted during the registration process. Submissions that do not adhere to the requirements listed above will be automatically disqualified. Intellectual Property Ownership of intellectual property is determined by the following: Each entrant retains title and full ownership in and to their submission. Entrants expressly reserve all intellectual property rights not expressly granted under the challenge agreement. By participating in the challenge, each entrant hereby irrevocably grants to sponsor and administrator a limited, non- exclusive, royalty-free, worldwide license and right to reproduce, publicly perform, publicly display, and use the submission to the extent necessary to administer the challenge, and to publicly perform and publicly display the submission, including, without limitation, for advertising and promotional purposes relating to the challenge. All entrants are encouraged to open source their code to the extent possible as a continuing contribution to cancer research. Dated: August 31, 2016. Michelle K. Lee, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. [FR Doc. 2016-21349 Filed 9-2-16; 8:45 am] BILLING CODE 3510-16-P
![61196 Federal Register / Vol. 81, No. 172 / Tuesday, September 6, 2016 / Notices
utility or plant application filed under should be made permanent. The USPTO ADDRESSES: All individuals or entities
35 U.S.C. 111(a) within the duration of seeks input from the public on the who wish to participate in the challenge
the pilot program; (3) the following: must register and submit their entry
nonprovisional application must 1. Have you participated in the through www.challenge.gov.
directly claim the benefit under 35 Extended Missing Parts Pilot Program? FOR FURTHER INFORMATION CONTACT: For
U.S.C. 119(e) and 37 CFR 1.78 of a prior If so, please discuss what aspects of the further information, please contact
provisional application filed within the program you think are beneficial and Thomas A. Beach, Office of the Under
previous 12 months, and the specific what aspects are not. Secretary and Director, at 571–272–
reference to the provisional application 2. Please discuss why an applicant 8600.
must be in an application data sheet would be discouraged from SUPPLEMENTARY INFORMATION:
under 37 CFR 1.76 (see 37 CFR participating in the Extended Missing
1.78(a)(3)); and (4) the applicant must Parts Pilot Program. I. About the Challenge
not have filed a nonpublication request. 3. Do you think the USPTO should Background
As required for all nonprovisional make the Extended Missing Parts Pilot
applications, the applicant must satisfy Program permanent? Why or why not? Cancer is undoubtedly a disease that
filing date requirements and publication 4. Please provide any other input that touches all our lives. Ending cancer as
requirements. If the application you would like the USPTO to consider we know it requires the formation of
submitted on filing does not meet the in determining whether the Extended new alliances. As President Obama
requirements for publication, or if the Missing Parts Pilot Program should be noted, getting this done isn’t just going
application is filed without any claims, made permanent. to take the best and brightest across the
the Office of Patent Application medical, research, and data
Dated: August 29, 2016. communities—but millions of
Processing will issue an appropriate
notice setting a two-month (extendable) Russell Slifer, Americans owning a stake of it. By
time period within which to respond. Deputy Under Secretary of Commerce for harnessing the power of patent data and
The Extended Missing Parts Pilot Intellectual Property and Deputy Director of accelerating the process for protecting
Program does not change the two-month the United States Patent and Trademark the intellectual property that leads to
Office. cancer immunotherapy breakthroughs,
time period set forth in any such notice.
[FR Doc. 2016–21306 Filed 9–2–16; 8:45 am] the USPTO is standing up and doing its
In accordance with 35 U.S.C. 122(b), the
USPTO will publish the application BILLING CODE 3510–16–P part to help bring potentially life-saving
promptly after the expiration of 18 treatments to patients, faster.
months from the earliest filing date for The Challenge
which benefit is sought. DEPARTMENT OF COMMERCE
If the applicant satisfies the With data released through the
Patent and Trademark Office USPTO Developer Hub, users are
requirements (discussed above) on filing
of the nonprovisional application and [Docket No. PTO–C–2016–0032] building rich visualizations of
the application is in condition for intellectual property data, an early
publication, the USPTO will send the USPTO Cancer Moonshot Challenge indicator of meaningful innovation and
applicant a Notice to File Missing Parts research and development (R&D), and
AGENCY: United States Patent and combining this data with other state or
of Nonprovisional Application that sets Trademark Office, Commerce.
a 12-month (non-extendable) time agency data, such as census and bureau
ACTION: Notice. of labor statistics, and/or economic and
period to submit the search fee, the
examination fee, any excess claims fees financial data. These types of
SUMMARY: The United States Patent and
(under 37 CFR 1.16(h)-(j)), and the visualizations demonstrate the power of
Trademark Office (USPTO) publishes
surcharge under 37 CFR 1.16(f) (for the telling complex stories that lead to
this notice to announce the Cancer
late submission of the search fee and impactful insights and ask why the data
Moonshot Challenge, which was
examination fee). If an applicant files a matters. Similarly, we challenge you to
launched on August 22, 2016, to enlist
timely reply to the Notice to File create and illuminate new trend lines
the public’s help to leverage the
Missing Parts within the 12-month time and interactive mappings of innovation
USPTO’s intellectual property data,
period and the nonprovisional with visualizations for all types of
often an early indicator of meaningful
application is completed, the cancer treatments and diagnostics by
research and development, and combine
nonprovisional application will be combining our data with other unique
it with other economic and funding
placed in the examination queue based data. Be sure to list the sources of your
data. This challenge supports the goals
on the actual filing date of the data sets (i.e., orange book data from the
and objectives of the National Cancer
nonprovisional application. FDA), tools, and assumptions used to
Moonshot, a Presidential initiative to
For additional discussion, see Pilot form your conclusion and
speed up cancer advances, make more
Program for Extended Time Period To visualizations. Imagine your data
therapies available to more patients, and
Reply to a Notice to File Missing Parts visualizations will be the foundation to
improve the ability to prevent cancer
of Nonprovisional Application, 75 FR empower the Federal Government—as
and detect it at an early stage. This
76401 (Dec. 8, 2010), 1362 Off. Gaz. Pat. well as the medical, research, and data
notice provides the public with
Office 44 (Jan. 4, 2011), and Extension communities—to make more precise
information on participation and
of the Extended Missing Parts Pilot funding and policy decisions based on
application requirements for the
the commercialization lifecycle of the
mstockstill on DSK3G9T082PROD with NOTICES
Program, 80 FR 80325 (Dec. 24, 2015), challenge, including the judging criteria,
1422 Off. Gaz. Pat. Office 192 (Jan. 19, most promising treatments, while
submission requirements, and rules of
2016). maximizing U.S. competitiveness in
eligibility.
cancer investments.
II. Request for Public Comments DATES: Challenge Deadline: The Using analytic tools, processes, and
The USPTO is requesting written deadline for submissions is September other interoperable data sets, we are
public comments on whether the 12, 2016, 5:00 p.m. Eastern Standard challenging you to develop interactive
Extended Missing Parts Pilot Program Time (EST). visualizations and stories that can help
VerDate Sep<11>2014 17:04 Sep 02, 2016 Jkt 238001 PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 E:\FR\FM\06SEN1.SGM 06SEN1](https://thefederalregister.org/doc/81_FR_61368/page/1.svg)
![61198 Federal Register / Vol. 81, No. 172 / Tuesday, September 6, 2016 / Notices
By submitting an entry to this • All entrants are encouraged to open the information will have practical
competition you represent and warrant source their code to the extent possible utility;
that your submission: as a continuing contribution to cancer • Evaluate the accuracy of the
• Is your own work and not copied (if research. agency’s estimate of the burden of the
we have reason to believe that your Dated: August 31, 2016. proposed collection of information,
submission is not your own work then Michelle K. Lee, including the validity of the
we may not consider it); Under Secretary of Commerce for Intellectual methodology and assumptions used;
• does not contain any third party Property and Director of the United States
intellectual property rights and/or • Propose ways to enhance the
Patent and Trademark Office.
content that you do not have quality, utility, and clarity of the
[FR Doc. 2016–21349 Filed 9–2–16; 8:45 am]
permission to use; and information to be collected; and
BILLING CODE 3510–16–P
• is not obscene, defamatory, or in • Propose ways to minimize the
breach of any applicable legislation or burden of the collection of information
regulations. on those who are to respond, including
The USPTO reserves the right to CORPORATION FOR NATIONAL AND through the use of appropriate
cancel, suspend, and/or modify the COMMUNITY SERVICE automated, electronic, mechanical, or
challenge, or any part of it, for any other technological collection
Information Collection; Submission for
reason, at the USPTO’s sole discretion. techniques or other forms of information
OMB Review, Comment Request
Submission Requirements technology.
AGENCY: Corporation for National and
• Your submission must use at least Community Service. Comments
the cancer research dataset provided by ACTION: Notice. A 60-day Notice requesting public
the USPTO.
• Your submission must be relevant comment was published in the Federal
SUMMARY: The Corporation for National
to a U.S. audience and must be in the Register on 06/10/2016 at 81 FR 37582.
and Community Service (CNCS) has
English language only. This comment period ended August 9,
submitted a public information
• You are responsible for the cost and collection request (ICR) entitled Senior 2016. No public comments were
expense (if any) of sending your Corps Project Progress Report (PPR)— received from this Notice.
submission to us and, if your OMB Control Number 3045–0033 for Description: The Senior Corps PPR
submission is selected, either attending review and approval in accordance with has two components: (1) Narratives and
an awards event demo at the USPTO on the Paperwork Reduction Act of 1995. work plans, and (2) the Progress Report
September 26, 2016, in person or Copies of this ICR, with applicable Supplement (PRS), which is an annual
submitting a video of your presentation supporting documentation, may be survey of volunteer demographics and
to be shared at the event. obtained by calling the Corporation for grantee characteristics.
• Only one project submission is National and Community Service, Jill
permitted per person or group. In the Type of Review: Renewal.
Sears, at 202–606–7577 or email to
event of a dispute over the identity of jsears@cns.gov. Individuals who use a Agency: Corporation for National and
an entrant, the submission will be telecommunications device for the deaf Community Service.
deemed submitted by the authorized (TTY–TDD) may call 1–800–833–3722 Title: Senior Corps Project Progress
account holder of the email address between 8:00 a.m. and 8:00 p.m. Eastern Report.
submitted during the registration Time, Monday through Friday.
process. OMB Number: 3045–0033.
DATES: Comments may be submitted,
Submissions that do not adhere to the identified by the title of the information Agency Number: None.
requirements listed above will be collection activity, within October 6, Affected Public: Sponsors of Senior
automatically disqualified. 2016. Corps grants.
Intellectual Property ADDRESSES: Comments may be Total Respondents: 1,250.
Ownership of intellectual property is submitted, identified by the title of the Frequency: Work plans and
determined by the following: information collection activity, to the narratives: Semi-Annual. Progress
• Each entrant retains title and full Office of Information and Regulatory Report Supplement: Annual.
ownership in and to their submission. Affairs, Attn: Ms. Sharon Mar, OMB
Desk Officer for the Corporation for Average Time per Response: Progress
Entrants expressly reserve all
National and Community Service, by Report and Supplement: Twelve hours.
intellectual property rights not
expressly granted under the challenge any of the following two methods Estimated Total Burden Hours: 15,000
agreement. within 30 days from the date of hours.
• By participating in the challenge, publication in the Federal Register: Total Burden Cost (capital/startup):
each entrant hereby irrevocably grants (1) By fax to: 202–395–6974, None.
to sponsor and administrator a limited, Attention: Ms. Sharon Mar, OMB Desk
Officer for the Corporation for National Total Burden Cost (operating/
non-exclusive, royalty-free, worldwide
license and right to reproduce, publicly and Community Service; or maintenance): None.
perform, publicly display, and use the (2) By email to: smar@omb.eop.gov. Authority: Pub. L. 104–13, (44 U.S.C.
mstockstill on DSK3G9T082PROD with NOTICES
submission to the extent necessary to SUPPLEMENTARY INFORMATION: The OMB Chapter 35)
administer the challenge, and to is particularly interested in comments Dated: August 30, 2016.
publicly perform and publicly display which:
Mikel Herrington,
the submission, including, without • Evaluate whether the proposed
limitation, for advertising and collection of information is necessary Director, Senior Corps.
promotional purposes relating to the for the proper performance of the [FR Doc. 2016–21327 Filed 9–2–16; 8:45 am]
challenge. functions of CNCS, including whether BILLING CODE 6050–28–P
VerDate Sep<11>2014 17:04 Sep 02, 2016 Jkt 238001 PO 00000 Frm 00018 Fmt 4703 Sfmt 9990 E:\FR\FM\06SEN1.SGM 06SEN1](https://thefederalregister.org/doc/81_FR_61368/page/3.svg)
Document Created: 2018-02-09 12:04:12
Document Modified: 2018-02-09 12:04:12
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Challenge Deadline: The deadline for submissions is September 12, 2016, 5:00 p.m. Eastern Standard Time (EST). | |
| Contact | For further information, please contact Thomas A. Beach, Office of the Under Secretary and Director, at 571-272-8600. | |
| FR Citation | 81 FR 61196 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR